ProjectA phase III, multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of…
Basic data
Title:
A phase III, multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of lamipalizumab administered intravitreally to patients with geographic atrophy secondary to age-related miacular degeneration
Duration:
01/04/2015 to 31/12/2018
Abstract / short description:
A phase III, multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of lamipalizumab administered intravitreally to patients with geographic atrophy secondary to age-related miacular degeneration
Keywords:
LAMIPALIZUMAB
AMD
clinical trial
klinische Studie
Involved staff
Managers
Center for Ophthalmology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
University Eye Hospital
Center for Ophthalmology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Grenzach-Wyhlen, Baden-Württemberg, Germany